424 related articles for article (PubMed ID: 16014054)
1. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
4. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
Bagheri N; Taziki O; Falaknazi K
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease.
Eustace JA; Astor B; Muntner PM; Ikizler TA; Coresh J
Kidney Int; 2004 Mar; 65(3):1031-40. PubMed ID: 14871424
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients.
Kato A; Takita T; Furuhashi M; Maruyama Y; Hishida A
Hemodial Int; 2010 Apr; 14(2):226-32. PubMed ID: 20345387
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
[TBL] [Abstract][Full Text] [Related]
8. Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Aragoncillo I; Verdalles U; Mosse A; Luño J
Kidney Int Suppl; 2008 Dec; (111):S67-70. PubMed ID: 19034331
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study.
Sarnak MJ; Poindexter A; Wang SR; Beck GJ; Kusek JW; Marcovina SM; Greene T; Levey AS
Kidney Int; 2002 Dec; 62(6):2208-15. PubMed ID: 12427147
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
11. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.
Menon V; Wang X; Greene T; Beck GJ; Kusek JW; Marcovina SM; Levey AS; Sarnak MJ
Am J Kidney Dis; 2003 Jul; 42(1):44-52. PubMed ID: 12830455
[TBL] [Abstract][Full Text] [Related]
12. Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.
Kubo S; Kitamura A; Imano H; Cui R; Yamagishi K; Umesawa M; Muraki I; Kiyama M; Okada T; Iso H;
J Atheroscler Thromb; 2016 Sep; 23(9):1089-98. PubMed ID: 26911856
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.
Soriano S; González L; Martín-Malo A; Rodríguez M; Aljama P
Clin Nephrol; 2007 Jun; 67(6):352-7. PubMed ID: 17598370
[TBL] [Abstract][Full Text] [Related]
14. Serum bicarbonate and long-term outcomes in CKD.
Menon V; Tighiouart H; Vaughn NS; Beck GJ; Kusek JW; Collins AJ; Greene T; Sarnak MJ
Am J Kidney Dis; 2010 Nov; 56(5):907-14. PubMed ID: 20605301
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
[TBL] [Abstract][Full Text] [Related]
17. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
19. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Selim G; Stojceva-Taneva O; Zafirovska K; Sikole A; Gelev S; Dzekova P; Stefanovski K; Koloska V; Polenakovic M
Prilozi; 2006 Jul; 27(1):133-44. PubMed ID: 16985487
[TBL] [Abstract][Full Text] [Related]
20. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
